Cargando…
Aptamer nucleotide analog drug conjugates in the targeting therapy of cancers
Aptamers are short single-strand oligonucleotides that can form secondary and tertiary structures, fitting targets with high affinity and specificity. They are so-called “chemical antibodies” and can target specific biomarkers in both diagnostic and therapeutic applications. Systematic evolution of...
Autores principales: | Li, Yongshu, Zhao, Jing, Xue, Zhichao, Tsang, Chiman, Qiao, Xiaoting, Dong, Lianhua, Li, Huijie, Yang, Yi, Yu, Bin, Gao, Yunhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760908/ https://www.ncbi.nlm.nih.gov/pubmed/36544906 http://dx.doi.org/10.3389/fcell.2022.1053984 |
Ejemplares similares
-
The application of Aptamer in biomarker discovery
por: Li, Yongshu, et al.
Publicado: (2023) -
Advances in Aptamer-Based Biomarker Discovery
por: Huang, Jie, et al.
Publicado: (2021) -
The Application of Microfluidic Technologies in Aptamer Selection
por: Liu, Yang, et al.
Publicado: (2021) -
Editorial: Aptamer-based structural biology, computational modelling, translational research and drug discovery, Volume II
por: Ma, Yuan, et al.
Publicado: (2023) -
Advances in Screening and Development of Therapeutic Aptamers Against Cancer Cells
por: Li, Zheng, et al.
Publicado: (2021)